Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 24% ± 4% | |
ciliated cell | 3 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of TLCD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 99% | 190.90 | 326 / 328 | 97% | 22.69 | 172 / 178 |
liver | 100% | 228.81 | 226 / 226 | 95% | 24.73 | 384 / 406 |
thymus | 99% | 166.78 | 644 / 653 | 96% | 21.62 | 580 / 605 |
prostate | 91% | 203.85 | 223 / 245 | 100% | 44.66 | 500 / 502 |
lung | 90% | 256.03 | 521 / 578 | 98% | 37.48 | 1135 / 1155 |
brain | 96% | 278.41 | 2533 / 2642 | 90% | 18.61 | 638 / 705 |
skin | 100% | 533.28 | 1809 / 1809 | 80% | 15.57 | 377 / 472 |
breast | 81% | 97.53 | 372 / 459 | 97% | 32.01 | 1086 / 1118 |
bladder | 76% | 124.24 | 16 / 21 | 98% | 43.88 | 492 / 504 |
stomach | 77% | 163.74 | 275 / 359 | 95% | 30.17 | 271 / 286 |
kidney | 100% | 460.02 | 89 / 89 | 63% | 13.48 | 568 / 901 |
intestine | 49% | 113.19 | 476 / 966 | 99% | 32.95 | 522 / 527 |
esophagus | 44% | 142.16 | 643 / 1445 | 98% | 24.18 | 180 / 183 |
adrenal gland | 98% | 163.27 | 254 / 258 | 33% | 4.78 | 77 / 230 |
uterus | 21% | 30.79 | 36 / 170 | 96% | 27.23 | 442 / 459 |
ovary | 19% | 13.30 | 34 / 180 | 98% | 24.40 | 420 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 82.51 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 21.30 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 83% | 13.06 | 24 / 29 |
eye | 0% | 0 | 0 / 0 | 76% | 18.00 | 61 / 80 |
adipose | 66% | 66.46 | 791 / 1204 | 0% | 0 | 0 / 0 |
heart | 36% | 31.86 | 307 / 861 | 0% | 0 | 0 / 0 |
spleen | 33% | 22.12 | 80 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 30% | 23.86 | 399 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 57.87 | 176 / 929 | 0% | 0 | 0 / 0 |
muscle | 6% | 4.75 | 45 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097035 | Biological process | regulation of membrane lipid distribution |
GO_0055091 | Biological process | phospholipid homeostasis |
GO_0071709 | Biological process | membrane assembly |
GO_0007009 | Biological process | plasma membrane organization |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TLCD1 |
Protein name | TLC domain-containing protein 1 (Calfacilitin) TLC domain containing 1 |
Synonyms | |
Description | FUNCTION: Regulates the composition and fluidity of the plasma membrane . Inhibits the incorporation of membrane-fluidizing phospholipids containing omega-3 long-chain polyunsaturated fatty acids (LCPUFA) and thereby promotes membrane rigidity . Does not appear to have any effect on LCPUFA synthesis . . |
Accessions | ENST00000580518.1 Q96CP7 K7ESD9 ENST00000581236.1 ENST00000292090.8 [Q96CP7-1] K7ELX5 ENST00000394933.7 [Q96CP7-2] |